Eric Bjerkholt joined Mirum as chief financial officer in September 2023. Eric joined Mirum from Chinook Therapeutics, Inc. where served as chief financial officer overseeing financial reporting, planning and budgeting, internal controls, investor relations, facilities, and information technology functions. Prior to Chinook, he served as CFO at Aimmune Therapeutics, Inc. Before Aimmune, Eric worked at Sunesis Pharmaceuticals, Inc., IntraBiotics Pharmaceuticals, Inc., LifeSpring Nutrition, Inc., and Age Wave, LLC. Prior to joining industry, Eric spent nearly a decade in healthcare investment banking at J.P. Morgan & Company, Inc. He is currently a member of the board of directors of CalciMedica, Inc., Cerus Corporation and Surrozen, Inc.
Eric holds an MBA from Harvard Business School and a Cand.Oecon degree from the University of Oslo in Norway.